H5N1 avian influenza virus vaccine (Vaxart)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameH5N1 avian influenza virus vaccine (Vaxart)

Drug Alias NameH5N1禽流感病毒疫苗 - VaxartBird flu vaccineAvian influenza vaccineND-1.1ND-1

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulantsToll like receptor 3 agonists

TargetsToll like receptor 3

Therapy Area/IndicationsInfluenza in Birds

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesVaxart Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVaxart Inc

Active IndicationsN/A

Inactive IndicationsInfluenza in Birds

Other Information

ATC CodeN/A